|
|
|
|
|
|
|
|
|
|
|
|
ROBERT L. EHRLICH, JR., Governor S.B. 333
|
|
|
|
|
|
|
(3) THE PRESIDENT OF THE MARYLAND BOARD OF PHARMACY,. OR THE
PRESIDENTS DESIGNEE;
(4) THE CHAIRMAN OF THE MARYLAND BOARD OF PHYSICIANS, OR THE
CHAIRMAN'S DESIGNEE;
(5) THE PRESIDENT OF THE MARYLAND BOARD OF NURSING. OR THE
PRESIDENTS DESIGNEE;
(5) [6) THE CHAIRMAN OF THE MARYLAND HEALTH CARE
COMMISSION, OR THE CHAIRMAN'S DESIGNEE;
(6) (7) TWO FOUR PHYSICIANS AND ONE NURSE PRACTITIONER WITH
EXPERTISE IN PHYSICAL MEDICINE AND REHABILITATION AREAS OF PRACTICE THAT
INVOLVE PAIN MANAGEMENT AND SUBSTANCE ABUSE AND ADDICTION TREATMENT,
APPOINTED BY THE SECRETARY AFTER CONSULTATION WITH:
(I) THE MEDICAL AND CHIRURGICAL FACULTY OF MARYLAND,
THE MARYLAND STATE MEDICAL SOCIETY, THE MARYLAND PHYSICAL MEDICINE
AND REHABILITATION SOCIETY, AND THE MARYLAND SOCIETY OF
ANESTHESIOLOGISTS WITH RESPECT TO THE PHYSICIAN APPOINTMENTS; AND
(II) THE MARYLAND NURSES ASSOCIATION WITH RESPECT TO THE
NURSE PRACTITIONER APPOINTMENT:
(7) (8) TWO THREE FOUR PHARMACISTS WHO REPRESENT THE
PERSPECTIVE OF INDEPENDENT AND CHAIN PHARMACIES AND PHARMACISTS,
APPOINTED BY THE SECRETARY AFTER CONSULTATION WITH THE MARYLAND
PHARMACISTS ASSOCIATION, THE MARYLAND ASSOCIATION OF CHAIN DRUG STORES,
EPIC PHARMACIES, AND ANY OTHER APPROPRIATE ORGANIZATION:
(I) TWO THREE OF WHOM REPRESENT THE PERSPECTIVE OF
INDEPENDENT AND CHAIN PHARMACIES AND PHARMACISTS; AND
(II) ONE OF WHOM REPRESENTS THE PERSPECTIVE OF HOSPITAL
OUTPATIENT PHARMACIES;
(8) (9) A FEDERAL LAW ENFORCEMENT OFFICIAL, APPOINTED BY THE
SECRETARY AFTER CONSULTATION WITH THE DRUG ENFORCEMENT
ADMINISTRATION OF THE UNITED STATES DEPARTMENT OF JUSTICE;
(9) (10) A STATE LAW ENFORCEMENT OFFICIAL, APPOINTED BY THE
SECRETARY AFTER CONSULTATION WITH THE MARYLAND STATE POLICE;
(10) (11) A LOCAL LAW ENFORCEMENT OFFICIAL, APPOINTED BY THE
SECRETARY AFTER CONSULTATION WITH THE MARYLAND CHIEFS OF POLICE
ASSOCIATION;
(11) (12) A PROSECUTOR, APPOINTED BY THE SECRETARY AFTER
CONSULTATION WITH THE MARYLAND STATE'S ATTORNEYS ASSOCIATION; AND
|
|
|
|
|
|
|
|
- 3025 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|